http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#Head http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#assertion http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#provenance http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#pubinfo http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#assertion http://purl.obolibrary.org/obo/DOID_1184 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_1184 http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00741 http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#association http://www.w3.org/2000/01/rdf-schema#label hydrocortisone tablets usp are indicated in the following conditions endocrine disorders primary or secondary adrenocortical insufficiency hydrocortisone or cortisone is the first choice synthetic analogs may be used in conjunction with mineralocorticoids where applicable in infancy mineralocorticoid supplementation is of particular importance congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer rheumatic disorders as adjunctive therapy for short term administration to tide the patient over an acute episode or exacerbation in psoriatic arthritis rheumatoid arthritis including juvenile rheumatoid arthritis selected cases may require low dose maintenance therapy ankylosing spondylitis acute and subacute bursitis acute nonspecific tenosynovitis acute gouty arthritis post traumatic osteoarthritis synovitis of osteoarthritis epicondylitis collagen diseases during an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus systemic dermatomyositis polymyositis acute rheumatic carditis dermatologic diseases pemphigus bullous dermatitis herpetiformis severe erythema multiforme stevens johnson syndrome exfoliative dermatitis mycosis fungoides severe psoriasis severe seborrheic dermatitis allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment seasonal or perennial allergic rhinitis serum sickness bronchial asthma contact dermatitis atopic dermatitis drug hypersensitivity reactions ophthalmic diseases severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as allergic conjunctivitis keratitis allergic corneal marginal ulcers herpes zoster ophthalmicus iritis and iridocyclitis chorioretinitis anterior segment inflammation diffuse posterior uveitis and choroiditis optic neuritis sympathetic ophthalmia respiratory diseases symptomatic sarcoidosis loeffler s syndrome not manageable by other means berylliosis fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy aspiration pneumonitis hematologic disorders idiopathic thrombocytopenic purpura in adults secondary thrombocytopenia in adults acquired autoimmune hemolytic anemia erythroblastopenia rbc anemia congenital erythroid hypoplastic anemia neoplastic diseases for palliative management of leukemias and lymphomas in adults acute leukemia of childhood edematous states to induce a diuresis or remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus gastrointestinal diseases to tide the patient over a critical period of the disease in ulcerative colitis regional enteritis nervous system acute exacerbations of multiple sclerosis miscellaneous tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy trichinosis with neurologic or myocardial involvement http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/SymptomaticReliefIndication https://identifiers.org/drugbank:DB00741 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#provenance http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#pubinfo http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#sig http://purl.org/nanopub/x/hasSignature G5i+RlY6Kegmo8kfTDj8bs8LQDnX+khpxSOkunI5KIpVqBYqWXNkCBuPdo6tieqZ+ywoA7z3jRHRiT8YNOR9tG25ca4vcvnzFXaBKgdrGbr7sGIzFUJi+N9NT5L2tfhCZd1PGHI+nFJ1Kh+KBiYWcdcF/Kiyw+dcIMOGXAZc4C4= http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8 http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8 http://purl.org/dc/terms/created 2021-06-13T12:40:53.988+02:00 http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAddRJC8DGmT6QQGOuL1gG33tSi2kYQ-4oDiEh0tWS0F8 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs